Africa: People With Light Skin Are At Higher Risk of Skin Cancer. How to Reduce Sun Exposure
[The Conversation Africa] Most skin cancers are caused by too much exposure to the sun - specifically solar ultraviolet (UV) radiation or rays. These can damage the cells in the skin and cause them to mutate. This causes skin cancer. Melanoma is the most fatal kind of skin cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 1, 2023 Category: African Health Source Type: news

'Haircut could save your life': Red flag signs of cancer could appear on your scalp
There are two main types of skin cancer - non-melanoma and melanoma. (Source: Daily Express - Health)
Source: Daily Express - Health - January 26, 2023 Category: Consumer Health News Source Type: news

ICYMI: Cancer death rate continues to decline due to treatment advances
This report is the latest to document this progress. A growing body of evidence underscores the role of new medicines in recent accelerated declines in mortality across a range of cancers.One study found, between 2000 and 2016 alone, new cancer medicines were associated with nearly 1.3 million averted cancer deaths across the 15 most common tumor types. In particular, new cancer medicines were associated with nearly 130,000 prevented breast cancer deaths, nearly 400,000 prevented lung cancer deaths, and over 6500 melanoma deaths. While the ACS report highlights tremendous progress in the fight against cancer, it also ...
Source: The Catalyst - January 25, 2023 Category: Pharmaceuticals Authors: Matthew Norawong Tags: Medicines in Development Cancer Drug Cost Equity Source Type: news

‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer
The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumoursIn December 2022, the US biotech firm Moderna, a company that emerged from relative obscurity to become a household name during the pandemic, published theresults of a clinical trialthat sent ripples through the world of cancer research.Conducted in partnership with the pharma company MSD, it demonstrated that a messenger RNA (mRNA) cancer vaccine, used in combination with immunotherapy, could offer significant benefit to patients with advanced melanoma who had received surgery to remove...
Source: Guardian Unlimited Science - January 22, 2023 Category: Science Authors: David Cox Tags: Cancer research Medical research Coronavirus Infectious diseases Science Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigatingTecentriq plusAvastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survivalNew adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 - Roche (SIX: RO, ROG;...
Source: Roche Investor Update - January 19, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigatingTecentriq plusAvastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survivalNew adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 - Roche (SIX: RO, ROG;...
Source: Roche Media News - January 19, 2023 Category: Pharmaceuticals Source Type: news

Regular Use of Vitamin D Linked to Fewer Melanoma Cases
TUESDAY, Jan. 17, 2023 -- Fewer melanoma cases are seen among individuals with regular use of oral vitamin D supplements, according to a study published online Dec. 28 in Melanoma Research. Emilia Kanasuo, from the University of Eastern Finland in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2023 Category: Pharmaceuticals Source Type: news

MPATH-Dx Version 2.0 Simplifies Classification of Melanoma
FRIDAY, Jan. 13, 2023 -- The Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) has been revised to simplify diagnoses into four classes, according to a consensus statement published online Jan. 11 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2023 Category: Pharmaceuticals Source Type: news

Rise in Cervical Cancer Mortality; Drug Active in Kids' Glioma; Vit D and Melanoma
(MedPage Today) -- A California study showed a concerning increase in cervical cancer mortality among women 65 or older, the age at which routine screening is no longer recommended. (UC Davis Comprehensive Cancer Center, Cancer Epidemiology, Biomarkers... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 13, 2023 Category: Hematology Source Type: news

Regular Vitamin D Supplements May Lower Melanoma Risk Regular Vitamin D Supplements May Lower Melanoma Risk
Taking vitamin D supplements, even just occasionally, may reduce an individual ' s risk of developing malignant melanoma, suggest the results of a Finnish retrospective analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pediatric Melanoma: Clinicopathologic Features, Survival Studied Pediatric Melanoma: Clinicopathologic Features, Survival Studied
"Better understanding of melanoma occurring in the first two decades of life is ... warranted," the study authors wrote.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 11, 2023 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Survival Rates High for Children, Teens With Melanoma
TUESDAY, Jan. 10, 2023 -- Survival rates for children and adolescents with melanomas are high, according to a study published online Dec. 9 in the Journal of the American Academy of Dermatology. Mary-Ann El Sharouni, Ph.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 10, 2023 Category: Pharmaceuticals Source Type: news

Tiny implantable device designed by UCLA scientists helps kill cancer
Many solid tumors resist treatment in part by turning human biology against itself. Tumors surround themselves with extra white blood cells known as regulatory T cells, which call off the body ’s natural defenses against the disease.Strategies to treat cancer by deactivating these cells risk creating other serious problems. Since regulatory T cells play an important role in safeguarding healthy tissues, diminishing them throughout the body can lead to other immune cells mistakenly attacking these tissues and causing autoimmune conditions that damage the colon, liver, heart and other organs.Now, an interdisciplinary UCLA ...
Source: UCLA Newsroom: Health Sciences - January 4, 2023 Category: Universities & Medical Training Source Type: news

Miami Cancer Institute to host inaugural Precision Oncology Symposium
Miami Cancer Institute, part of Baptist Health, announced it is hosting its inaugural Precision Oncology Symposium February 3-4, 2023, at the Biltmore Hotel in Coral Gables, Florida. The educational symposium is designed to provide an overview about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcoma and brain tumors — with novel targeted agents and treatment combinations. “We… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 1, 2023 Category: American Health Authors: Baptist Health Source Type: news

Adverse Events Linked to Better Survival With ICIs in Melanoma Adverse Events Linked to Better Survival With ICIs in Melanoma
With immune checkpoint inhibitors (ICIs), survival is improved even among patients who develop higher-grade immune adverse events leading to hospitalization, a new study reveals.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news